Dimensional Fund Advisors LP Purchases 191,857 Shares of GRAIL, Inc. $GRAL

Dimensional Fund Advisors LP increased its holdings in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 88.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 408,650 shares of the company's stock after acquiring an additional 191,857 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.95% of GRAIL worth $21,104,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. lifted its position in shares of GRAIL by 154,361.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 91,132 shares of the company's stock worth $7,531,000 after purchasing an additional 91,073 shares during the period. Vanguard Group Inc. raised its stake in GRAIL by 9.0% in the fourth quarter. Vanguard Group Inc. now owns 1,980,783 shares of the company's stock worth $169,535,000 after buying an additional 163,790 shares in the last quarter. WIM INVESTMENT MANAGEMENT Ltd raised its stake in GRAIL by 68.9% in the fourth quarter. WIM INVESTMENT MANAGEMENT Ltd now owns 106,400 shares of the company's stock worth $9,107,000 after buying an additional 43,400 shares in the last quarter. Pictet Asset Management Holding SA lifted its holdings in GRAIL by 1,036.8% during the fourth quarter. Pictet Asset Management Holding SA now owns 40,926 shares of the company's stock worth $3,585,000 after buying an additional 37,326 shares during the period. Finally, Profund Advisors LLC lifted its holdings in GRAIL by 141.2% during the fourth quarter. Profund Advisors LLC now owns 22,776 shares of the company's stock worth $1,949,000 after buying an additional 13,334 shares during the period.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Weiss Ratings reiterated a "sell (d-)" rating on shares of GRAIL in a report on Friday, July 17th. Wall Street Zen upgraded GRAIL from a "sell" rating to a "hold" rating in a research note on Saturday, May 9th. Mizuho lifted their target price on GRAIL from $58.00 to $65.00 and gave the company a "neutral" rating in a research note on Wednesday, July 15th. Piper Sandler boosted their target price on shares of GRAIL from $54.00 to $56.00 and gave the stock a "neutral" rating in a report on Wednesday, May 6th. Finally, The Goldman Sachs Group began coverage on shares of GRAIL in a research report on Friday, June 5th. They set a "neutral" rating and a $60.00 price target for the company. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, GRAIL has an average rating of "Hold" and a consensus target price of $67.78.

GRAIL Price Performance

GRAIL stock opened at $63.40 on Friday. The stock has a market capitalization of $2.72 billion, a price-to-earnings ratio of -6.50 and a beta of 3.24. GRAIL, Inc. has a 1-year low of $29.95 and a 1-year high of $118.84. The business has a fifty day moving average price of $66.76 and a 200-day moving average price of $66.48.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported ($2.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.66) by $0.10. The company had revenue of $44.69 million for the quarter, compared to analyst estimates of $42.39 million. GRAIL had a negative return on equity of 16.05% and a negative net margin of 236.95%. On average, equities research analysts anticipate that GRAIL, Inc. will post -10.91 earnings per share for the current fiscal year.

Insider Activity at GRAIL

In related news, insider Andrew John Partridge sold 1,491 shares of GRAIL stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $61.08, for a total value of $91,070.28. Following the completion of the sale, the insider directly owned 163,738 shares in the company, valued at $10,001,117.04. This trade represents a 0.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.83% of the stock is owned by insiders.

GRAIL Company Profile

GRAIL, Inc NASDAQ: GRAL is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company's platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRAIL, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source